dm+d

89695009

Articles

Compatibility of nebuliser solution combinations

22 June 2022Guidance on what to consider when mixing nebuliser solutions and advice on which combinations are compatible.

How should medicines be dosed in children who are obese?

28 May 2021Review on how to calculate medicine doses in children who are obese which includes a table on commonly prescribed medicines.
Search Articles

Refrigerated Storage

TobiMylan

Mylan
Tobi
Nebuliser solution 300mg/5ml

In the event of an inadvertent temperature excursion the following data may be used:
After removal from the refrigerator, or if refrigeration is unavailable, TOBI pouches (intact or opened) may be stored at up to 25°C for up to 28 days.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk.

23 February 2022
London MI Service

BramitobChiesi Ltd

Chiesi Ltd
Bramitob
300 mg/4ml Nebuliser Solution

In the event of an inadvertent temperature excursion the following data may be used:

Prior to dispensing: Contact Chiesi Ltd in all cases where a deviation from the recommended storage conditions has occurred.

In use shelf life: Bramitob bags (intact or opened) may be stored for up to 3 months at not more than 25°C.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

Yes
21 October 2021
London MI Service

VantobraPARI Pharma GmbH 

PARI Pharma GmbH 
Vantobra
Nebuliser solution

In the event of an inadvertent temperature excursion the following data may be used:

The product can be stored <25°C for 4 weeks.

The product can be returned to the fridge and no change in expiry date is required if exposed to the above conditions.

Please refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

20 January 2022
London MI Service

Lactation Safety Information

Parenteral / Inhalation

Parenteral / Inhalation
Gentamicin for parenteral use.
No aminoglycoside alternative for inhalation use
Limited published evidence of safety for parenteral use and no published evidence regarding administration via inhalation, although not considered to pose an increased risk
Small amounts in breast milk
Minimal absorption from the infant's GI tract
11 September 2020

For ophthalmic use

For ophthalmic use
Yes
11 September 2020